1. Home
  2. STVN vs BEPC Comparison

STVN vs BEPC Comparison

Compare STVN & BEPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • BEPC
  • Stock Information
  • Founded
  • STVN 1949
  • BEPC 2019
  • Country
  • STVN Italy
  • BEPC United States
  • Employees
  • STVN N/A
  • BEPC N/A
  • Industry
  • STVN Containers/Packaging
  • BEPC Electric Utilities: Central
  • Sector
  • STVN Consumer Discretionary
  • BEPC Utilities
  • Exchange
  • STVN Nasdaq
  • BEPC Nasdaq
  • Market Cap
  • STVN 5.7B
  • BEPC 4.9B
  • IPO Year
  • STVN 2021
  • BEPC N/A
  • Fundamental
  • Price
  • STVN $21.55
  • BEPC $28.06
  • Analyst Decision
  • STVN Buy
  • BEPC Buy
  • Analyst Count
  • STVN 6
  • BEPC 3
  • Target Price
  • STVN $25.08
  • BEPC $32.00
  • AVG Volume (30 Days)
  • STVN 334.9K
  • BEPC 1.3M
  • Earning Date
  • STVN 05-08-2025
  • BEPC 05-02-2025
  • Dividend Yield
  • STVN 0.27%
  • BEPC 5.14%
  • EPS Growth
  • STVN N/A
  • BEPC N/A
  • EPS
  • STVN 0.45
  • BEPC 0.70
  • Revenue
  • STVN $1,143,012,735.00
  • BEPC $4,571,000,000.00
  • Revenue This Year
  • STVN $8.42
  • BEPC $24.39
  • Revenue Next Year
  • STVN $10.36
  • BEPC $7.09
  • P/E Ratio
  • STVN $47.85
  • BEPC $39.99
  • Revenue Growth
  • STVN 1.72
  • BEPC 0.93
  • 52 Week Low
  • STVN $16.56
  • BEPC $23.01
  • 52 Week High
  • STVN $28.77
  • BEPC $35.14
  • Technical
  • Relative Strength Index (RSI)
  • STVN 52.82
  • BEPC 55.45
  • Support Level
  • STVN $21.13
  • BEPC $26.35
  • Resistance Level
  • STVN $22.46
  • BEPC $28.33
  • Average True Range (ATR)
  • STVN 1.25
  • BEPC 1.13
  • MACD
  • STVN 0.07
  • BEPC 0.19
  • Stochastic Oscillator
  • STVN 75.56
  • BEPC 94.23

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About BEPC Brookfield Renewable Corporation

Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia, and totals over 20 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners LP and Brookfield Renewable Corp.

Share on Social Networks: